You should not take APRISO® (mesalamine) extended-release capsules if you experience an allergic reaction to salicylates or aminosalicylates (sulfasalazine), or to any of the components of APRISO capsules. It is recommended that you have an evaluation of kidney function prior to treatment with APRISO therapy and periodically while on therapy. Talk to your doctor if you have any kidney or renal problems before taking APRISO.

    Pay $0 co-pay on your first APRISO prescription, then no more than $10 on all future prescriptions for the duration of the program*

    Save on your out-of-pocket expense

    With APRISO, we can not only help maintain remission of ulcerative colitis (UC), but we can also help you maintain your budget. Ulcerative colitis can be a challenging condition to keep under control, but money does not have to come between a patient with UC and maintaining remission.

    If you have already received an APRISO Savings Card from your healthcare provider, all you have to do is activate it.

    We need to know a little more about you before you can activate or download your card. Please fill out the information below.
    Please note, in order to download your card, you must have Adobe<sup>®</sup> Reader<sup>®</sup> installed on your computer. If you do not have this program, <a target="_newtab" onclick="urlclick('https://acrobat.adobe.com/us/en/products/pdf-reader.html');"><strong>click here</strong></a> to download.
    <span>* = required.</span>
    Please wait...
    All personal information will be kept confidential and will not be shared with any parties other than Salix Pharmaceuticals and its designated partners. <a href="/privacy-policy"><strong>View our full Privacy Policy</strong></a>.

    • *Maximum benefit of $110 off the first use; maximum benefit of $100 off each subsequent use. You could pay more than $10 if your co-pay or retail cost exceeds $110. Void where prohibited by law. This offer is not valid for prescriptions reimbursed in whole or in part by Medicaid, Medicare, or federally or state-funded programs. See printed card for full eligibility criteria.

    Indication for APRISO

    APRISO® is a locally acting aminosalicylate indicated for the maintenance of remission of ulcerative colitis in patients 18 years and older.

    The use of APRISO for treating ulcerative colitis beyond 6 months has not been evaluated in controlled clinical trials.

    Important Safety Information about APRISO

    You should not take APRISO® (mesalamine) extended-release capsules if you experience an allergic reaction to salicylates or aminosalicylates (sulfasalazine), or to any of the components of APRISO capsules.

    It is recommended that you have an evaluation of kidney function prior to treatment with APRISO therapy and periodically while on therapy. Talk to your doctor if you have any kidney or renal problems before taking APRISO.

    Mesalamine has been associated with an acute intolerance syndrome that may be difficult to distinguish from a flare of your ulcerative colitis. Symptoms include cramping, acute abdominal (stomach) pain and bloody diarrhea, sometimes fever, headache, and rash. Talk to your doctor if you experience a worsening of these problems after you start treatment.

    If you have liver disease, talk to your doctor before taking APRISO. There have been reports of liver failure in patients with liver disease who have taken mesalamine.

    You should not take APRISO while taking antacids because the dissolving of APRISO granules depends on pH. If you are 65 years old or older, talk to your doctor before taking APRISO. Blood cell count must be monitored closely if you are 65 or older and on mesalamine therapy. Additionally, if you have phenylketonuria (PKU), please be aware that APRISO contains 2.24 mg of phenylalanine per day.

    In the clinical studies, the most common side effects occurring in at least 3% of adult patients taking APRISO were headache, diarrhea, upper abdominal (stomach) pain, nausea, nasopharyngitis (inflammation of the nasal passages), flu and flu-like illness, and inflammation of the sinuses.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch/ or call 1-800-FDA-1088.

    For product information, adverse event reports, and product complaint reports, please contact:

    Salix Product Information Call Center
    Phone: 1-800-508-0024
    Fax: 1-510-595-8183
    Email: customerservice@salix.com

    Please see complete Prescribing Information for APRISO.PDF

    GM 13/107